申请人:ICONIX PHARM INC
公开号:WO2003043577A2
公开(公告)日:2003-05-30
Compounds of formula (1) modulate the activity of Rho C, wherein n is 2 to 5, inclusive; R1, R2, R3, R4, R5, R6, R7, R8, and R9 are each independently halo, lower alkyl, lower alkoxy, lower alkylamino, trifluoromethyl, nitro, lower alkylthio, or two adjacent residues form cycloalkyl, cycloalkenyl, aryl, or lower alkylenedioxy; and pharmaceutically acceptable salts thereof.